MOHAP reports 83 Covid-19 cases on 17 April; no timeline to ease hospital mandates

MOHAP reported 83 new Covid-19 cases and 75 recoveries on 17 April 2026. The virus still circulates at low but steady levels across the UAE, more than six years into the pandemic.

The daily count sits well below the peaks of 2022, when the UAE recorded thousands of infections per day during the Omicron wave. But double-digit daily figures in mid-2026 force a practical question for healthcare operators: how long should pandemic-era protocols and costs stay embedded in standard operations?

What the numbers show

The 83-case figure continues the pattern MOHAP has tracked through Q1 2026. Daily counts have fluctuated between 50 and 120 cases since January, with no sustained upward trend. The 75 recoveries reported alongside new infections suggest active case counts are roughly stable rather than accumulating.

MOHAP stopped publishing hospitalisation and ICU figures alongside daily tallies in late 2024, when it shifted to a shorter reporting format. When severe outcomes were climbing, the ministry published them. The current reporting cadence suggests case severity remains low enough that hospital capacity is not under pressure.

The UAE conducted more than 196 million PCR tests over the course of the pandemic, one of the highest per-capita testing rates globally. Current surveillance relies on sentinel testing at primary care facilities, hospital-based detection, and voluntary reporting.

Operational cost for providers

For hospital COOs and infection control teams, the steady case flow means Covid-specific protocols cannot yet be retired. Facilities licensed by DHA and the Department of Health Abu Dhabi (DOH) are still required to maintain isolation capacity and report positive cases through emirate-level notification systems.

A 2024 DOH audit estimated that infection control overhead added 4–6% to operating costs at mid-sized Abu Dhabi hospitals, spread across:

• PPE procurement and stockpile rotation
• Dedicated staffing for patient screening
• IT systems for mandatory case reporting

Most operators have absorbed these costs into baseline budgets rather than treating them as temporary pandemic spending.

For CFOs evaluating budget allocations, the question is whether MOHAP will relax current surveillance mandates before year-end. The ministry has not announced any timeline for reclassifying Covid-19 from a notifiable disease to routine seasonal monitoring. Until that reclassification happens, reporting obligations and their associated costs remain fixed.

What to watch

The UAE's approach in 2026 tracks the path taken by Singapore, which completed its transition to seasonal respiratory illness monitoring in February 2025, and South Korea, which followed in June 2025. Both countries maintained formal surveillance infrastructure longer than most Western nations before making the shift.

MOHAP's next quarterly communicable disease bulletin, expected in May 2026, may clarify whether the ministry is preparing a similar move. Operators should watch for two specific signals:

• Any reduction in mandatory reporting frequency
• Any change to Covid-19's classification within MOHAP's notifiable disease list

At 83 cases a day, Covid-19 is endemic. The remaining question for operators is how much surveillance infrastructure to maintain, and at what cost, for a pathogen that generates compliance paperwork but rarely fills ICU beds.